MiNK Therapeutics, Inc. (INKT) Tops Q4 EPS by 44c
Tweet
Share
E-mailGet Alerts INKT Hot Sheet
Join SI Premium – FREE
MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q4 EPS of $0.23, $0.44 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
- Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
